1. Home
  2. WAFD vs KYMR Comparison

WAFD vs KYMR Comparison

Compare WAFD & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAFD
  • KYMR
  • Stock Information
  • Founded
  • WAFD 1917
  • KYMR 2015
  • Country
  • WAFD United States
  • KYMR United States
  • Employees
  • WAFD N/A
  • KYMR N/A
  • Industry
  • WAFD Major Banks
  • KYMR Medicinal Chemicals and Botanical Products
  • Sector
  • WAFD Finance
  • KYMR Health Care
  • Exchange
  • WAFD Nasdaq
  • KYMR Nasdaq
  • Market Cap
  • WAFD 2.6B
  • KYMR 3.0B
  • IPO Year
  • WAFD N/A
  • KYMR 2020
  • Fundamental
  • Price
  • WAFD $32.64
  • KYMR $40.66
  • Analyst Decision
  • WAFD Hold
  • KYMR Buy
  • Analyst Count
  • WAFD 5
  • KYMR 16
  • Target Price
  • WAFD $36.60
  • KYMR $54.00
  • AVG Volume (30 Days)
  • WAFD 464.5K
  • KYMR 532.5K
  • Earning Date
  • WAFD 01-14-2025
  • KYMR 02-20-2025
  • Dividend Yield
  • WAFD 3.19%
  • KYMR N/A
  • EPS Growth
  • WAFD N/A
  • KYMR N/A
  • EPS
  • WAFD 2.50
  • KYMR N/A
  • Revenue
  • WAFD $704,024,000.00
  • KYMR $87,563,000.00
  • Revenue This Year
  • WAFD N/A
  • KYMR N/A
  • Revenue Next Year
  • WAFD $12.61
  • KYMR $33.16
  • P/E Ratio
  • WAFD $13.07
  • KYMR N/A
  • Revenue Growth
  • WAFD 0.44
  • KYMR 86.92
  • 52 Week Low
  • WAFD $25.79
  • KYMR $22.35
  • 52 Week High
  • WAFD $38.62
  • KYMR $53.27
  • Technical
  • Relative Strength Index (RSI)
  • WAFD 32.31
  • KYMR 40.14
  • Support Level
  • WAFD $35.42
  • KYMR $37.09
  • Resistance Level
  • WAFD $35.92
  • KYMR $44.17
  • Average True Range (ATR)
  • WAFD 1.08
  • KYMR 2.70
  • MACD
  • WAFD -0.47
  • KYMR -0.51
  • Stochastic Oscillator
  • WAFD 19.76
  • KYMR 33.47

About WAFD WaFd Inc.

WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.

Share on Social Networks: